Ankylosing Spondylitis Disease Activity Score with ESR (ASDAS-ESR)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۰ • واحد: points
حداقل ۰ — حداکثر ۱۰ • واحد: points
حداقل ۰ — حداکثر ۱۰ • واحد: points
حداقل ۰ — حداکثر ۱۰ • واحد: points
حداقل ۰ — حداکثر ۲۰۰ • واحد: mm/hr
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Inactive0–1.3
- Moderate1.3–2.1
- High2.1–3.5
- Very High3.5–10
The Ankylosing Spondylitis Disease Activity Score with ESR (ASDAS-ESR) calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include back pain. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically ESR. The ASDAS-ESR is a composite index to assess disease activity in axial spondyloarthritis, combining patient-reported outcomes with laboratory measures to provide a comprehensive evaluation of disease activity.
Clinical Indication
The Ankylosing Spondylitis Disease Activity Score with ESR (ASDAS-ESR) is indicated for bedside clinical practice to support Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically ESR. The ASDAS-ESR is a composite index to assess disease activity in axial spondyloarthritis, combining patient-reported outcomes with laboratory measures to provide a comprehensive evaluation of disease activity.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.
Limitations & Contraindications
Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.
Clinical Pearls & Action Plan
Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology.
ASDAS-ESR = 0.08 × Back Pain + 0.07 × Duration of Morning Stiffness + 0.11 × Patient Global + 0.09 × Peripheral Pain/Swelling + 0.29 × √(ESR)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| back_pain | integer | Yes | Overall level of AS neck, back, or hip pain (0-10 scale)(points) |
| morning_stiffness | integer | Yes | Overall level of morning stiffness from the time you wake up (0-10 scale)(points) |
| patient_global | integer | Yes | How active was your spondylitis, on average, during the last week (0-10 scale)(points) |
| peripheral_pain | integer | Yes | Overall level of pain/swelling in joints other than neck, back, or hips (0-10 scale)(points) |
| esr | integer | Yes | Erythrocyte Sedimentation Rate(mm/hr) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1.3 | Inactive | Inactive disease |
| 1.3–2.1 | Moderate | Moderate disease activity |
| 2.1–3.5 | High | High disease activity |
| 3.5–10 | Very High | Very high disease activity |
Evidence-Based References (EBM)
- Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Jan;68(1):18-24. doi: 10.1136/ard.2008.094870.DOI: 10.1136/ard.2008.094870
- van der Heijde D, Lie E, Kvien TK, Sieper J, van den Bosch F, Listing J, Braun J, Landewé R. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826.DOI: 10.1136/ard.2008.100826
- Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594.DOI: 10.1136/ard.2010.138594